Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Clinical trial NCT00610168 · COMPLETED

Trial details

NCT number: NCT00610168
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria

Start date: 2008-01-01
Primary completion: 2008-04-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.